Chemed Co. (NYSE:CHE) Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC boosted its position in Chemed Co. (NYSE:CHE) by 0.3% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 50,740 shares of the company’s stock after buying an additional 140 shares during the period. ProShare Advisors LLC owned approximately 0.34% of Chemed worth $27,531,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. TD Asset Management Inc lifted its stake in shares of Chemed by 164.3% in the fourth quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock valued at $120,328,000 after purchasing an additional 127,934 shares during the period. Thrivent Financial for Lutherans grew its position in shares of Chemed by 300.3% in the second quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock valued at $63,249,000 after purchasing an additional 87,449 shares during the period. Epoch Investment Partners Inc. grew its holdings in Chemed by 85.2% in the 4th quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company’s stock valued at $88,977,000 after buying an additional 70,001 shares during the period. Impax Asset Management Group plc grew its holdings in Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock valued at $172,510,000 after purchasing an additional 51,974 shares during the period. Finally, Los Angeles Capital Management LLC acquired a new stake in shares of Chemed during the 1st quarter worth $26,776,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the transaction, the director now directly owns 3,446 shares in the company, valued at $1,991,615.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Chemed news, EVP Nicholas Michael Westfall sold 2,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total value of $1,123,160.00. Following the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at $3,363,864.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director George J. Walsh III sold 200 shares of Chemed stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total transaction of $115,590.00. Following the completion of the sale, the director now owns 3,446 shares in the company, valued at $1,991,615.70. The disclosure for this sale can be found here. In the last three months, insiders sold 6,744 shares of company stock worth $3,828,231. 3.32% of the stock is currently owned by insiders.

Chemed Price Performance

Shares of NYSE:CHE opened at $589.28 on Tuesday. The business has a 50-day moving average of $570.39 and a two-hundred day moving average of $576.80. The firm has a market capitalization of $8.92 billion, a PE ratio of 31.72, a P/E/G ratio of 2.31 and a beta of 0.44. Chemed Co. has a 12 month low of $497.36 and a 12 month high of $654.62.

Chemed (NYSE:CHE) last released its quarterly earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The company had revenue of $595.88 million for the quarter, compared to analyst estimates of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The business’s revenue was up 7.6% on a year-over-year basis. During the same period last year, the firm posted $4.71 earnings per share. As a group, research analysts anticipate that Chemed Co. will post 21.77 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $2.00 dividend on an annualized basis and a yield of 0.34%. This is an increase from Chemed’s previous quarterly dividend of $0.40. Chemed’s dividend payout ratio is currently 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.